摘要
目的研究调节性B细胞(Breg)对慢加急性肝衰竭(ACLF)小鼠的免疫调节作用。方法 CCl4诱导造ACLF模型,分离脾脏、肝脏、外周血淋巴细胞,流式细胞仪检测CD19+IL-10+B细胞比例,ELISA法检测IL-10表达水平。结果 ACLF组小鼠的24 h存活率低于对照组(20%vs 100%,P<0.001),ACLF小鼠肝脏、脾脏、外周血CD19+IL-10+B细胞比例高于对照组,分别为(2.97±0.33)%vs(0.75±0.11)%,(4.13±0.67)%vs(0.79±0.11)%,(5.87±1.00)%vs(0.68±0.09)%,差异均有统计学意义(均P<0.001)。ACLF小鼠肝脏、脾脏、外周血IL-10的分泌水平高于对照组,分别为(16.76±1.73)pg/ml vs(6.29±0.70)pg/ml,(21.21±1.62)pg/ml vs(8.23±1.52)pg/ml,(31.32±2.95)pg/ml vs(7.49±1.22)pg/ml,差异均有统计学意义(均P<0.001)。结论调节性B细胞可能在CCl4诱导的慢加急性肝衰竭小鼠疾病进展中起重要作用。
Objective To observe the immunoregulatory role of regulatory B cells (Breg) in Acute-on-Chronic Liver Failure (ACLF) mice. Methods Hepatic lymphocytes, splenic lymphocytes and peripheral blood lymphocytes were obtained from a total of thirty CCh-induced ACLF mice, and the percent of CD19^+IL-10^+ B cells were determined by flow cytometry (FCM). IL-10 concentration in the lymphocytes culture supernatant was measured by ELISA. Results Compared to control group, the 24 hours overall survival rate of ACLF group was improved(20% vs 100%, P〈
.001 ). And it was accompanied by a significantly increased number of IL-10-producing CD19^+ B cells in liver, spleen and peripheral blood of ACLF mice (2.97±0.33)% vs (0.75±0.11 )%, (4.13±0.67)% vs (0.79±0.11)%, (5.87±1.00)% vs (0.68±0.09)%,P〈0.001, respectively. The concentrations of IL-10 in the supernatant of cultured lymphocytes, from liver, spleen and peripheral blood, separately, were also elevated in ACLF mice(16.76±1.73)pg/m vs (6.29±0.70)pg/ml, (21.21±1.62)pg/m vs (8.23±1.52)pg/ml, (31.32±2.95)pg/m vs (7.49±1.22)pg,/ml, P〈0.001, respectively. Conehmion Our data indicated that increase in Breg cells and IL-10 concentration might play an critical role in the immunopathogenesis of ACLF.
出处
《热带医学杂志》
CAS
2015年第7期863-866,874,共5页
Journal of Tropical Medicine
基金
国家"十二五"重大传染病防治项目(2012ZX10002004-002)
广东省自然科学基金(9151040701000019)
广州市产学研协同创新重大专项-民生科技研究